Cargando…

Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis

Groups of F344 rats were administered biweekly intraperitoneal injections of N‐hydroxy‐3,2′‐dimethyl‐4‐aminobiphenyl (N‐OH‐DMAB) at a dose of 5, 10 or 20 mg/kg body weight or DMAB, the parent compound, at a dose of 25 mg/kg body weight, for a total of 10 times. Prostate carcinomas in the ventral lob...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirai, Tomoyuki, Iwasaki, Shogo, Naito, Hatsumi, Masui, Tsuneo, Kato, Toshio, Imaida, Katsumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918925/
https://www.ncbi.nlm.nih.gov/pubmed/1517147
http://dx.doi.org/10.1111/j.1349-7006.1992.tb01968.x
_version_ 1783317522751160320
author Shirai, Tomoyuki
Iwasaki, Shogo
Naito, Hatsumi
Masui, Tsuneo
Kato, Toshio
Imaida, Katsumi
author_facet Shirai, Tomoyuki
Iwasaki, Shogo
Naito, Hatsumi
Masui, Tsuneo
Kato, Toshio
Imaida, Katsumi
author_sort Shirai, Tomoyuki
collection PubMed
description Groups of F344 rats were administered biweekly intraperitoneal injections of N‐hydroxy‐3,2′‐dimethyl‐4‐aminobiphenyl (N‐OH‐DMAB) at a dose of 5, 10 or 20 mg/kg body weight or DMAB, the parent compound, at a dose of 25 mg/kg body weight, for a total of 10 times. Prostate carcinomas in the ventral lobe developed in a N‐OH‐DMAB dose‐dependent manner (0, 17.6 and 66.7%, respectively) with limited tumor yields in other organs. Although intraperitoneal administration of DMAB was similarly found to induce prostate tumors, it also caused severe chemical peritonitis, which resulted in a high mortality. The present data confirmed that intraperitoneal administration of N‐OH‐DMAB provides a relatively specific induction method for models of prostate carcinogenesis.
format Online
Article
Text
id pubmed-5918925
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59189252018-05-11 Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis Shirai, Tomoyuki Iwasaki, Shogo Naito, Hatsumi Masui, Tsuneo Kato, Toshio Imaida, Katsumi Jpn J Cancer Res Article Groups of F344 rats were administered biweekly intraperitoneal injections of N‐hydroxy‐3,2′‐dimethyl‐4‐aminobiphenyl (N‐OH‐DMAB) at a dose of 5, 10 or 20 mg/kg body weight or DMAB, the parent compound, at a dose of 25 mg/kg body weight, for a total of 10 times. Prostate carcinomas in the ventral lobe developed in a N‐OH‐DMAB dose‐dependent manner (0, 17.6 and 66.7%, respectively) with limited tumor yields in other organs. Although intraperitoneal administration of DMAB was similarly found to induce prostate tumors, it also caused severe chemical peritonitis, which resulted in a high mortality. The present data confirmed that intraperitoneal administration of N‐OH‐DMAB provides a relatively specific induction method for models of prostate carcinogenesis. Blackwell Publishing Ltd 1992-07 /pmc/articles/PMC5918925/ /pubmed/1517147 http://dx.doi.org/10.1111/j.1349-7006.1992.tb01968.x Text en
spellingShingle Article
Shirai, Tomoyuki
Iwasaki, Shogo
Naito, Hatsumi
Masui, Tsuneo
Kato, Toshio
Imaida, Katsumi
Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis
title Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis
title_full Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis
title_fullStr Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis
title_full_unstemmed Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis
title_short Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis
title_sort dose dependence of n‐hydroxy‐3,2′‐dimethym‐aminobiphenyl‐induced rat prostate carcinogenesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918925/
https://www.ncbi.nlm.nih.gov/pubmed/1517147
http://dx.doi.org/10.1111/j.1349-7006.1992.tb01968.x
work_keys_str_mv AT shiraitomoyuki dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis
AT iwasakishogo dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis
AT naitohatsumi dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis
AT masuitsuneo dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis
AT katotoshio dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis
AT imaidakatsumi dosedependenceofnhydroxy32dimethymaminobiphenylinducedratprostatecarcinogenesis